Patents Assigned to Tangshan People's Hospital
  • Publication number: 20240133890
    Abstract: The present disclosure provides the use of BAZ1B_K426hy in the preparation of a product for tumor detection and belongs to the field of biotechnology. The present disclosure further provides a group of immunogenic polypeptides, including polypeptide A and polypeptide B. An anti-BAZ1B_K426hy polyclonal antibody is prepared by conducting mixed immunization on an animal with the immunogenic polypeptide. The polyclonal antibody can specifically recognize an endogenous protein BAZ1B_K426hy by enzyme-linked immunosorbent assay (ELISA)/Dot blot/Western blot, which is used for preparation of detection products for tumors and Williams syndrome.
    Type: Application
    Filed: April 13, 2023
    Publication date: April 25, 2024
    Applicants: Tangshan People's Hospital, North China University of Science and Technology, Tangshan Maternal And Child Health Hospital
    Inventors: Jingwu LI, Yufeng Li, Shuqing Wang, Jinghua Zhang, Jinghua Wu, Fen Hu, Yuan Yu, Yan Liu, Yuhui Li, Xuan Zheng